These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30320504)

  • 1. Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?
    Ollivier M; Haissaguerre M; Ferriere A; Tabarin A
    Eur J Endocrinol; 2018 Oct; 179(5):L1-L2. PubMed ID: 30320504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Feelders RA; Hofland LJ; de Herder WW
    Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.
    Corcuff JB; Young J; Masquefa-Giraud P; Chanson P; Baudin E; Tabarin A
    Eur J Endocrinol; 2015 Apr; 172(4):473-81. PubMed ID: 25624013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France.
    Young J; Bertherat J; Vantyghem MC; Chabre O; Senoussi S; Chadarevian R; Castinetti F;
    Eur J Endocrinol; 2018 May; 178(5):447-458. PubMed ID: 29472378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial.
    Fleseriu M; Pivonello R; Elenkova A; Salvatori R; Auchus RJ; Feelders RA; Geer EB; Greenman Y; Witek P; Cohen F; Biller BMK
    Lancet Diabetes Endocrinol; 2019 Nov; 7(11):855-865. PubMed ID: 31542384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with ketoconazole as a therapy for patients with Cushing's syndrome.
    McCance DR; Hadden DR; Kennedy L; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 1987 Nov; 27(5):593-9. PubMed ID: 3450457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal liver failure due to ketoconazole treatment of a girl with Cushing's syndrome.
    Zöllner E; Delport S; Bonnici F
    J Pediatr Endocrinol Metab; 2001 Mar; 14(3):335-8. PubMed ID: 11308052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's disease: adrenal steroidogenesis inhibitors.
    Pivonello R; Simeoli C; Di Paola N; Colao A
    Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.
    Valassi E; Aulinas A; Glad CA; Johannsson G; Ragnarsson O; Webb SM
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):433-439. PubMed ID: 28665508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of diabetes mellitus in Cushing's syndrome.
    Munir A; Newell-Price J
    Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ketoconazole in pre-operative treatment in Cushing's syndrome: three cases report.
    Li KL; Tung SC; Wang PW
    Changgeng Yi Xue Za Zhi; 1996 Dec; 19(4):358-63. PubMed ID: 9041768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the Patient Treated with Steroidogenesis Inhibitors.
    Castinetti F; Nieman LK; Reincke M; Newell-Price J
    J Clin Endocrinol Metab; 2021 Jun; 106(7):2114-2123. PubMed ID: 33675650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of ketoconazole in the treatment of Cushing disease].
    Pascal V; Denet S; Weryha G; Kaminski P; Leclère J; Hartemann P
    Rev Med Interne; 1993 Jan; 14(1):58-61. PubMed ID: 8362113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
    Halioui-Louhaichi S; Azzabi O; Nefzi L; Ben Hariz M; Ben Mrad N; Ben Ammar B; Maherzi A
    Arch Pediatr; 2005 Jul; 12(7):1120-3. PubMed ID: 15964528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and long-term tolerance of ketoconazole in the treatment of Cushing's disease].
    Tabarin A; Navarranne A; Corcuff B; Guerin J; Kern AM; Roger P
    Ann Endocrinol (Paris); 1990; 51(1):27-32. PubMed ID: 2171415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the treatment of Cushing's syndrome using ketoconazole].
    Conget JI; Halperin I; Vendrell J; Ferrer J; Martínez-Osaba MJ; Esmatjes E; Vilardell E
    Med Clin (Barc); 1989 Nov; 93(14):531-4. PubMed ID: 2695699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment for Cushing's syndrome].
    Nishikawa T; Saito J; Omura M
    Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.